Tacurion Pharma
Latest round
- Series D
Last raised
- Apr 2013
Total raised
- $15M
Investors
- 3
About Tacurion Pharma
Tacurion Pharma, Inc.Tacurion Pharma, Inc. specializes in the development of therapeutics with a focus on underserved medical needs. The company is headquartered in Bridgewater, US.Tacurion Pharma, Inc. is engaged in the development of innovative pharmaceutical products aimed at addressing significant medical needs.Tacurion Pharma, Inc. generates revenue primarily through the commercialization of its pharmaceutical products, adopting a business model that fosters direct engagement with healthcare providers and institutions. plans to accelerate the development of its pipeline therapies targeting specific medical conditions.
Who invested in Tacurion Pharma
3 investors across 1 round
See all investors in Tacurion Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Apr 8, 2013
Amount
$15M
Investors
Questions about Tacurion Pharma
Who invested in Tacurion Pharma?
Tacurion Pharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tacurion Pharma raised?
Tacurion Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tacurion Pharma last raise money?
Tacurion Pharma's most recent round on record is a Series D, in Apr 2013.
What does Tacurion Pharma do?
Tacurion Pharma is a pharmaceuticals company.
Where is Tacurion Pharma headquartered?
Tacurion Pharma is headquartered in Bridgewater, US.
Which VCs invest in companies like Tacurion Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Tacurion Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Tacurion Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.